Privi Speciality Chemicals share price
NSE: PRIVISCLBSE: 530117Chemicals & PetrochemicalsSmall Cap
Privi Speciality Chemicals Limited · Formerly Fairchem Speciality · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, May 2015 on NSE
Last close ₹3,296.30down ₹179.60 (5.17%)BSE ₹3,297.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,475.90.
29 Oct: open ₹3,500.00, high ₹3,575.00, low ₹3,270.10
52-week range of traded prices to 29 Oct 2026
₹2,570.80Low, 21 Jan 2026₹3,785.30High, 22 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12,876 Cr505th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.30%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.61
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,84,49935.1% delivered
About Privi Speciality Chemicals
Privi Speciality Chemicals Limited makes and exports aroma chemicals, the ingredients that give scent to perfumes, cleaning products and other personal care and home care goods, for fragrance houses and FMCG (fast-moving consumer goods) companies.123 It makes them at plants in Mahad, Maharashtra, and Jhagadia, Gujarat, and sells to customers across Europe, Asia and the Americas.14
Its products span pinene (a compound from pine trees), musk, phenol (a basic industrial chemical) and citral (a lemon-scented compound) chemistry and speciality molecules, and include Dihydromyrcenol, Amber Fleur, Terpineol, Galaxmusk, Indomerane and Amber Woody Xtreme.52 Its 6 units at Mahad make pinene-based products, citral and speciality molecules, and its 1 unit at Jhagadia makes phenols and musk.63 It processes crude sulphate turpentine (CST), a by-product of the pulp and paper industry, into alpha and beta-pinene, key raw materials for its pine-based products.65 It has 2 research centres, at Mahad and Nerul, and exports to more than 40 countries.78
The company was incorporated on 25 May 1985 and was demerged from Fairchem Speciality in 2021, when it became independently listed.910 Its promoters are Mahesh Purshottam Babani, its chairman and managing director, and Bhaktavatsala Rao Doppalapudi, its executive director.1112 Its wholly owned subsidiaries are Privi Biotechnologies and Privi Speciality USA Corporation.13
Privi Speciality Chemicals key points
Results
- In the year to Mar 2026, consolidated revenue from operations rose 22.01% to ₹2,563.69 crore from ₹2,101.19 crore.14
- Consolidated EBITDA (earnings before interest, tax, depreciation and amortisation) for the year to Mar 2026 was ₹665.45 crore against ₹474.16 crore, a margin of 25.8% against 22.35%, and profit after tax was ₹316.72 crore against ₹184.75 crore.15
- In the quarter to Jun 2026, consolidated revenue from operations was ₹666.22 crore against ₹558.81 crore a year earlier, and EBITDA was ₹167.47 crore, up 18.73%, a margin of 24.58%.1617
Market position
Where revenue comes from
- Consolidated revenue from products by customer location202122Exports made up 67% of total revenue in the year to Mar 2026.
Item year to Mar 2026 year to Mar 2025 India ₹83,126.02 lakh ₹62,720.86 lakh Outside India ₹171,050.36 lakh ₹146,455.78 lakh Of which United States ₹52,342.23 lakh ₹40,032.19 lakh Of which Switzerland ₹24,545.43 lakh ₹25,191.92 lakh
Plants and capacity
- Installed capacity was 48,000 MTPA (metric tonnes a year) in the year to Mar 2026, and on its earnings call of 31 Jul 2026 the company said its plants run at around 90% of capacity.2324
- On its earnings call of 31 Jul 2026, the company said Phase I, to 54,000 metric tons, had moved from June to September 2026, and Phase II, to 66,000 metric tons, would finish by September 2027; its documents give no Phase I outcome.1725
- The company stated in its annual report for the year to Mar 2026 that its 3 expansion phases are expected to lift installed capacity to around 72,000 MTPA by September 2028.26
Customers and partners
- Its customers include fragrance houses Givaudan, Firmenich, Symrise, Mane, International Flavors & Fragrances (IFF) and Takasago, and FMCG companies Procter & Gamble, Reckitt Benckiser, Henkel and Colgate-Palmolive.27
- It serves 15 global fragrance and flavour houses and supplies 4 FMCG companies directly, and no single customer made up 10% or more of consolidated revenue in the year to Mar 2026.2829
- About 70% of its business is under long-term supply agreements with global fragrance houses and 30% is spot business (sold order by order at current prices).30
Joint venture with Givaudan
- PRIGIV (Prigiv Specialties) is a joint venture, 51% owned by the company and 49% by Givaudan, that develops and makes speciality products at a plant in Mahad.3132
- The company said in its annual report of 10 Jul 2026 that about 25 of the 42 speciality molecules planned under PRIGIV had been commercialised, and that PRIGIV made a profit after tax in the quarter to Mar 2026.3331
- On its earnings call of 31 Jul 2026, asked about the quarter to Jun 2026, the company said PRIGIV's revenue was about ₹18 crore and its EBITDA about 14% to 15%.34
- On 26 Mar 2026, PRIGIV allotted new shares under a ₹50 crore equity investment, of which the company put in ₹25.5 crore and Givaudan the rest.3536
What the company expects
- In its presentation of 30 Jul 2026, the company said it is on track for revenue of ₹5,000 crore and EBITDA of over ₹1,000 crore by the year to Mar 2030, with EBITDA margins expected to stay above 20%.37
- On its earnings call of 31 Jul 2026, the company said capital spending this year and the next 2 years could be ₹850 crore to ₹900 crore, completing Phase II and Phase III.38
- On its earnings call of 31 Jul 2026, the company said furfural chemistry, from corn cob to maltol (a flavour ingredient), ethyl maltol and cyclopentanone, would add about ₹1,000 crore and more of revenue.39
Recent events
- On 7 Sep 2026, the National Company Law Tribunal (the court that approves mergers) ordered a meeting of the company's shareholders on 27 Oct 2026 to consider merging Privi Fine Sciences and Privi Biotechnologies into the company; the company's documents give no outcome.40
- On 30 Jun 2026, ICRA assigned a credit rating (an agency's view of repayment risk) of AA with a stable outlook to a ₹300 crore term loan from ICICI Bank.41
- On 5 May 2026 and 6 May 2026, the company received no-objection letters from the NSE and BSE for merging Privi Fine Sciences and Privi Biotechnologies into the company.42
- On 19 Dec 2025, the board approved merging Privi Fine Sciences and Privi Biotechnologies into the company, with 1 new company share for every 135 Privi Fine Sciences shares.4342
Last updated
All 43 sources, each with its page
- 1. Annual report, 10 Jul 2026, page 6
- 2. Annual report, 10 Jul 2026, page 10
- 3. Annual report, 10 Jul 2026, page 46
- 4. Annual report, 10 Jul 2026, page 11
- 5. Annual report, 10 Jul 2026, page 9
- 6. Annual report, 10 Jul 2026, page 30
- 7. Annual report, 10 Jul 2026, page 32
- 8. Annual report, 10 Jul 2026, page 30
- 9. Annual report, 10 Jul 2026, page 106
- 10. Annual report, 10 Jul 2026, page 8
- 11. Annual report, 10 Jul 2026, page 63
- 12. Annual report, 10 Jul 2026, page 26
- 13. Annual report, 10 Jul 2026, page 48
- 14. Annual report, 10 Jul 2026, page 46
- 15. Annual report, 10 Jul 2026, page 46
- 16. Investor presentation, 30 Jul 2026, page 7
- 17. Earnings call, 31 Jul 2026, page 5
- 18. Annual report, 10 Jul 2026, page 46
- 19. Annual report, 10 Jul 2026, page 45
- 20. Annual report, 10 Jul 2026, page 159
- 21. Annual report, 10 Jul 2026, page 159
- 22. Annual report, 10 Jul 2026, page 11
- 23. Annual report, 10 Jul 2026, page 18
- 24. Earnings call, 31 Jul 2026, page 12
- 25. Earnings call, 31 Jul 2026, page 8
- 26. Annual report, 10 Jul 2026, page 31
- 27. Annual report, 10 Jul 2026, page 74
- 28. Annual report, 10 Jul 2026, page 38
- 29. Annual report, 10 Jul 2026, page 159
- 30. Annual report, 10 Jul 2026, page 23
- 31. Annual report, 10 Jul 2026, page 17
- 32. Annual report, 10 Jul 2026, page 47
- 33. Annual report, 10 Jul 2026, page 12
- 34. Earnings call, 31 Jul 2026, page 9
- 35. Exchange filing, 9 Feb 2026, page 1
- 36. Exchange filing, 26 Mar 2026, page 1
- 37. Investor presentation, 30 Jul 2026, page 19
- 38. Earnings call, 31 Jul 2026, page 14
- 39. Earnings call, 31 Jul 2026, page 14
- 40. Exchange filing, 6 Oct 2026, page 1
- 41. Exchange filing, 30 Jun 2026, page 1
- 42. Annual report, 10 Jul 2026, page 49
- 43. Annual report, 10 Jul 2026, page 48
Results
Consolidated; ₹ crore.Privi Speciality Chemicals quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +17.5%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Sep 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹760 Crup 14.14%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹118 Crup 41.88%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 15.5%
Revenue by quarter
Peak revenue ₹760 Cr, quarter to Sep 2026; lowest ₹491 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 491 | 614 | 559 | 679 | 605 | 722 | 666 | 760 |
| Net profit | 44 | 64 | 58 | 90 | 75 | 94 | 83 | 118 |
| Net margin | 9.1% | 10.4% | 10.3% | 13.3% | 12.4% | 13.0% | 12.4% | 15.5% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹2,564 Crup 22.01%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹317 Crup 71.43%
- Net margin
- 12.4%
Revenue by year
Net profit by year, a loss in red
The years either side of a change of basis do not compare. From the year to Mar 2021, part of the business was demerged on 21 Aug 2020, and figures before the change include the part that left.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 597 | 1,040 | 1,341 | 1,631 | 1,277 | 1,404 | 1,608 | 1,752 | 2,101 | 2,564 |
| Net profit | 21 | 53 | 94 | 176 | 117 | 97 | 21 | 95 | 185 | 317 |
| Net margin | 3.6% | 5.1% | 7.0% | 10.8% | 9.2% | 6.9% | 1.3% | 5.4% | 8.8% | 12.4% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Aroma Chemical Manufacturing, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement. Its history crosses a change of basis in the accounts in the year to Mar 2021: days before it are of the company before the change.Privi Speciality Chemicals PE ratio and valuation
Price to book
At or below today's level on 73% of 1,923 trading days since Nov 2018.
LowestHighest
Its median5.72Industry median2.41
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 74% of 2,451 trading days over the last 10 years.
LowestHighest
Its median0.19%Industry median0.55%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +70.3% | +71.4% | −0.9% | 0.3% |
| 3 years | +40.5% | +146.0% | −43.0% | 0.3% |
| 5 years | +27.9% | +22.1% | +4.6% | 0.2% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth over 5 years includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the year to Mar 2021.
Mutual fund holdings
44 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 5 of the 8 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 44 funds holding Privi Speciality Chemicals
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 25
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 7
- CutCut. Funds that held fewer shares than at the end of the month before.
- 8
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 4
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 1
| Fund | |||
|---|---|---|---|
 SBI Small Cap FundSBI Mutual Fund | 19,00,000 | 1.66% | ₹681.5 Cr |
| SBI Children's Fund - InvestmentSBI Mutual Fund | 3,78,805 | 1.71% | ₹135.9 Cr |
| SBI Multi Asset Allocation FundSBI Mutual Fund | 2,71,991 | 0.46% | ₹97.6 Cr |
| SBI MNC FundSBI Mutual Fund | 1,60,000 | 0.90% | ₹57.4 Cr |
 TRUSTMF Small Cap FundTrust Mutual Fund | 97,794 | 0.90% | ₹35.1 Cr |
 Nippon India Nifty Smallcap 250 Index FundNippon India Mutual Fund | 20,651 | 0.21% | ₹7.41 Cr |
 HDFC Nifty Smallcap 250 ETFHDFC Mutual Fund | 16,208 | 0.21% | ₹5.81 Cr |
| SBI Nifty Smallcap 250 Index FundSBI Mutual Fund | 10,491 | 0.21% | ₹3.76 Cr |
 Motilal Oswal Nifty Smallcap 250 Index FundMotilal Oswal Mutual Fund | 7,441 | 0.21% | ₹2.67 Cr |
 ICICI Prudential Nifty Smallcap 250 Index FundICICI Prudential Mutual Fund | 4,703 | 0.22% | ₹1.69 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Privi Speciality Chemicals insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group0 purchases, 1 saleNo purchase₹1,030 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹1,030 Cr
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Privi Speciality Chemicals competitors and peers
Specialty Chemicals, 130 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Privi Speciality Chemicals in market cap.Chemical companies
Privi Speciality Chemicals is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Fine Organic IndustriesFINEORG | 15,796 | 36.05 | 5.93 | +7.3% | +5.7% | 17.7% | 17.6% | 0.21% |
 AtulATUL | 15,151 | 19.63 | 2.30 | +18.1% | +42.4% | 12.4% | 12.5% | 0.58% |
 BASF IndiaBASF | 13,696 | 21.30 | 3.46 | +6.7% | +62.4% | 16.9% | 20.2% | 0.79% |
 Anupam Rasayan IndiaANURAS | 13,457 | 77.02 | 4.04 | +51.8% | +41.5% | 5.7% | 6.2% | 0.13% |
 Sudeep PharmaSUDEEPPHRM | 12,764 | 67.58 | 13.33 | – | – | 22.5% | 20.1% | 0.13% |
 Vinati OrganicsVINATIORGA | 10,767 | 24.01 | 3.41 | +5.1% | +5.4% | 15.1% | 17.3% | 0.82% |
 Elantas Beck IndiaELANTAS | 10,373 | 55.51 | 9.40 | +18.9% | +35.3% | 18.3% | 18.8% | 0.06% |
 Jubilant IngreviaJUBLINGREA | 9,045 | 25.80 | 2.73 | +15.4% | +21.7% | 11.0% | 12.0% | 0.88% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Privi Speciality Chemicals dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹10.00 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 4 Nov 2026 | Interim | ₹5.00 |
| 31 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹10.00 |
| 24 Jul 2025 | Final | ₹5.00 |
| 24 Jul 2024 | Final | ₹2.00 |
| 20 Sep 2022 | Final | ₹2.00 |
| 17 Aug 2021 | Final | ₹2.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Privi Speciality Chemicals announcements
Oct 2026
29 Oct · Results
23 Oct · Analysts
Privi Speciality Chemicals share price by year
Each calendar year to 2025.Privi Speciality Chemicals share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 2,804.40 | +59.2% | 3,388.00 | 1,414.15 |
| 2024 | 1,762.05 | +49.8% | 1,971.95 | 988.40 |
| 2023 | 1,176.25 | +2.9% | 1,321.70 | 875.95 |
| 2022 | 1,143.35 | −37.2% | 2,227.75 | 1,034.60 |
| 2021 | 1,819.25 | +242.4% | 1,965.30 | 539.00 |
| 2020Demerger | 531.25 | +10.7% | 741.65 | 374.10 |
| 2019 | 479.75 | +35.4% | 560.20 | 327.55 |
| 2018 | 354.25 | −29.5% | 497.90 | 331.60 |
| 2017 | 502.20 | −0.8% | 583.45 | 379.10 |
| 2016 | 506.15 | +100.3% | 528.50 | 199.10 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. With the demerger of 21 Aug 2020 reinvested, the change in 2020 is +43.9%.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | 3,530.50 | 3,533.30 | 3,466.10 | 3,475.90 | 3,501.16 | 85,373 | 47.7% |
| 27 Oct 2026 | 3,361.50 | 3,570.00 | 3,345.90 | 3,530.50 | 3,512.37 | 1,72,170 | 59.2% |
| 26 Oct 2026 | 3,252.00 | 3,383.50 | 3,211.10 | 3,356.00 | 3,340.46 | 1,05,465 | 61.5% |
| 23 Oct 2026 | 3,322.10 | 3,327.20 | 3,190.10 | 3,250.20 | 3,246.71 | 82,711 | 63.6% |
| 22 Oct 2026 | 3,314.30 | 3,387.00 | 3,289.40 | 3,330.60 | 3,335.03 | 80,904 | 51.6% |
| 21 Oct 2026 | 3,283.00 | 3,349.00 | 3,154.00 | 3,292.40 | 3,241.72 | 1,09,226 | 48.3% |
| 19 Oct 2026 | 3,360.10 | 3,360.10 | 3,266.00 | 3,283.00 | 3,297.26 | 54,122 | 59.6% |
| 16 Oct 2026 | 3,365.90 | 3,367.80 | 3,336.10 | 3,349.00 | 3,350.92 | 29,563 | 68.8% |
| 15 Oct 2026 | 3,388.60 | 3,397.60 | 3,340.00 | 3,365.10 | 3,366.04 | 53,324 | 57.0% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Demerger history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 21 Aug 2020 | Demerger | 0.7696 | Part of the business became a separate company. The factor is the opening price on the ex-date divided by the previous close. The chart shows earlier prices with the demerger reinvested. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- PRIVISCL
- BSE code
- 530117
- ISIN
- INE959A01019
- Industry
- Chemicals & Petrochemicals
- Former symbols
- FAIRCHEM, ADI
- Website
- www.privi.com
- CIN
- L15140MH1985PLC286828
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1985
- Registered office
- Plot No. A-71, TTC, Thane-Belapur Road, Near Kopar Khairane, Navi Mumbai 400709, Maharashtra
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, Nifty Smallcap 250, BSE SmallCap, Nifty Total Market, BSE Commodities, BSE 1000